# Two-year Efficacy and Safety of Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/two-year-efficacy-and-safety-of-benralizumab-in-the-treatment-of-eosinophilic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael E. Wechsler,Parameswaran Nair,Nader Khalidi,B. Terrier,B. Hellmich,Arnaud Bourdin,David Jayne,David J. Jackson,Florence Roufosse,Christian Pagnoux,U. Specks,Lena Börjesson Sjö,C.N. Ho,Maria Jison,Christopher McCrae,S. Necander,Eva Rodríguez‐Suárez,A. Shavit,C. Walton,Peter A. Merkel |
| Citations | 0 |
| DOI | 10.1164/ajrccm.2025.211.abstracts.a5029 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4410274085 |
| Type | conference-abstract |
| Year | 2025 |

## Paper authors

- [C.N. Ho](https://scholariq.org/researchers/c-n-ho/)

## Paper primary topic

- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)

## Paper topics

- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.